Derivatives and Hedging	9 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging	12. Derivatives and Hedging Foreign Exchange Forward Contracts The Company uses derivative financial instruments to manage exposures to foreign currency risk that may or may not be designated as hedging instruments. The Company’s objective for holding derivatives is to use the most effective methods to minimize the impact of these exposures. The Company does not enter into derivatives for speculative or trading purposes. The Company enters into foreign exchange forward contracts to attempt to mitigate the effect of gains and losses generated by foreign currency transactions related to certain operating expenses and re-measurement of certain assets and liabilities denominated in foreign currencies. For foreign exchange forward contracts not designated as hedging instruments, the fair value of the Company’s derivatives in a gain position are recorded in “Prepaid expenses and other current assets” and derivatives in a loss position are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. Changes in the fair value of derivatives are recorded in “Other income (expense), net” in the accompanying condensed consolidated statements of operations. As of March 31, 2025 and June 30, 2024, foreign exchange forward contracts not designated as hedging instruments had a total notional principal amount of $52.2 million and $31.3 million, respectively. During the three months ended March 31, 2025 and 2024, the net gains and losses recorded in the condensed consolidated statement of operations from these contracts were net gains of $0.6 million and net losses of $0.3 million, respectively. During the nine months ended March 31, 2025 and 2024 the net gains and losses recorded in the condensed consolidated statement of operations were net losses of $0.7 million and net losses of less than $0.1 million, respectively. Changes in the fair value of these foreign exchange forward contracts are offset largely by remeasurement of the underlying assets and liabilities. There were no foreign exchange forward contracts that were designated as hedging instruments as of March 31, 2025 or June 30, 2024. For the three months ended March 31, 2025 and 2024, the Company recognized foreign currency transaction net losses of $0.9 million and foreign currency transaction net gains of $0.7 million, respectively, and for the nine months ended March 31, 2025 and 2024, the Company recognized foreign currency transaction net gains of $0.5 million and $0.4 million, respectively, related to the change in fair value of foreign currency denominated assets and liabilities.

Derivatives and Hedging

9 Months Ended

Mar. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

12.

Derivatives and Hedging

Foreign Exchange Forward Contracts

The Company uses derivative financial instruments to manage exposures to foreign currency risk that may or may not be designated as hedging instruments. The Company’s objective for holding derivatives is to use the most effective methods to minimize

the impact of these exposures. The Company does not enter into derivatives for speculative or trading purposes. The Company enters into foreign exchange forward contracts to attempt to mitigate the effect of gains and losses generated by foreign currency transactions related to certain operating expenses and re-measurement of certain assets and liabilities denominated in foreign currencies.

For foreign exchange forward contracts not designated as hedging instruments, the fair value of the Company’s derivatives in a gain position are recorded in “Prepaid expenses and other current assets” and derivatives in a loss position are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. Changes in the fair value of derivatives are recorded in “Other income (expense), net” in the accompanying condensed consolidated statements of operations. As of March 31, 2025 and June 30, 2024, foreign exchange forward contracts not designated as hedging instruments had a total notional principal amount of $52.2 million and $31.3 million, respectively. During the three months ended March 31, 2025 and 2024, the net gains and losses recorded in the condensed consolidated statement of operations from these contracts were net gains of $0.6 million and net losses of $0.3 million, respectively. During the nine months ended March 31, 2025 and 2024 the net gains and losses recorded in the condensed consolidated statement of operations were net losses of $0.7 million and net losses of less than $0.1 million, respectively. Changes in the fair value of these foreign exchange forward contracts are offset largely by remeasurement of the underlying assets and liabilities.

There were no foreign exchange forward contracts that were designated as hedging instruments as of March 31, 2025 or June 30, 2024.

For the three months ended March 31, 2025 and 2024, the Company recognized foreign currency transaction net losses of $0.9 million and foreign currency transaction net gains of $0.7 million, respectively, and for the nine months ended March 31, 2025 and 2024, the Company recognized foreign currency transaction net gains of $0.5 million and $0.4 million, respectively, related to the change in fair value of foreign currency denominated assets and liabilities.